Over the last decade, the outlook for patients with rheumatoid arthritis (RA) has improved, but there is growing interest in preventing RA by treating individuals in pre-arthritic phases of disease.

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Rheumatoid arthritis prevention in patients at the subclinical or pre-clinical stage remains ...

Please provide your email address to receive an email when new articles are posted on . For the prevention of rheumatoid arthritis to become feasible, it may be necessary to intervene as soon as ...

Rheumatoid arthritis (RA) is currently diagnosed and treated when an individual presents with signs and symptoms of inflammatory arthritis (IA) as well as other features, such as autoantibodies and/or ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

Rheumatoid arthritis has traditionally been framed as a self-contained autoimmune disease confined to joints, yet mounting clinical and molecular evidence now argues that it functions as a hub within ...

Rheumatoid arthritis (RA) is a chronic, incurable disorder, so treatment focuses on managing the disease and controlling its progression. Although current treatments help control RA symptoms in most ...

Artiva reported positive early clinical data for its AlloNK cell therapy in patients with difficult-to-treat rheumatoid arthritis and other autoimmune diseases. ・The U.S. Food and Drug Administration ...

Rheumatoid arthritis (RA) is an inflammatory disorder affecting the joints. RA usually starts between the ages of 25 and 45 years, but it can sometimes present in older people. RA may cause symptoms ...